Physician profile
Kevin D Smith
NPI 1891735932
$35,771.52
in general payments reported to CMS, 2019-2025
12 companies · $2,214 in 2025
The $2,214 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $192 · 2021: $3,163 · 2022: $648 · 2023: $1,770 · 2024: $3,701 · 2025: $2,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,651 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000 · Food and Beverage: $1,693 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $900 · Consulting Fee: $350 · Entertainment: $83.33 · Education: $7.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,651.19 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
| Food and Beverage | $1,692.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $900.00 |
| Consulting Fee | $350.00 |
| Entertainment | $83.33 |
| Education | $7.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $26,537.27 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $4,563.35 | 2022-2025 | Infuse, Biotrue One Day |
| Johnson & Johnson Vision Care, INC. | $2,558.15 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $1,310.60 | 2019-2025 | Dailies Total1, Precision 1, Air Optix |
| Coopervision INC. | $389.60 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Oyster Point Pharma, INC. | $149.93 | 2022-2023 | Tyrvaya |
| Optos, INC. | $109.79 | 2021-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $42.86 | 2022 | |
| Glaukos Corporation | $30.31 | 2022 | |
| Abb Con-Cise Optical Group LLC | $28.62 | 2019 | |
| Dompe US, INC. | $27.20 | 2025 | Oxervate |
| Biotissue Holdings INC. | $23.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.